Delisting risk
NexGel (NXGL)
Manufactures customizable hydrogels and sells consumer, white-label, and licensed surgical biomaterials.
$0.3750
Pre-market+0.02 (+6.35%)
At close$0.3526(−1.51%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions17 holders · as of Mar 31, 2026 | 5.98% | 506.6K shares | |
| Insiders8 holders · as of Jun 23, 2026 | 15.00% | 1.27M shares | |
| Otherremainder | 79.02% | 6.70M shares |
8.48M company shares as of Aug 22, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Two share counts disagree (9.75M in the company's Sep 3, 2026 report, 8.48M elsewhere); stakes use the report.
Institutions13F, as of Mar 31, 2026
17 holders · 506.6K shares · 6 new positions · 11 increased · 2 reduced · 9 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Geode Capital Management, LLC | 128.5K | 1.52% | +61.5K | May 15, 2026 |
| Morgan Stanley | 55.0K | 0.65% | −30.4K | May 15, 2026 |
| Renaissance Technologies LLC | 51.0K | 0.60% | −4.3K | May 14, 2026 |
| Vanguard Capital Management LLC | 48.9K | 0.58% | +48.9Knew | May 15, 2026 |
| Jane Street Group, LLC | 42.1K | 0.50% | +12.7K | May 12, 2026 |
| Simon Quick Advisors, LLC | 35.7K | 0.42% | 0 | May 6, 2026 |
| Vanguard Fiduciary Trust Co | 34.0K | 0.40% | +34.0Knew | May 15, 2026 |
| Flax Pond Capital, LLC | 20.0K | 0.24% | +20.0Knew | May 19, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Asymmetry Point LP | 8.80% | 745.0K | 13G | Apr 29, 2026 ↗ |
Insider tradesForm 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jun 23, 2026 | Adam R. Levydirector, officer: Chief Executive Officer | Sale | 5,000 | $0.5933 | 322,692 |
| Jun 18, 2026 | Adam R. Levydirector, officer: Chief Executive Officer | Sale | 6,000 | $0.5921 | 327,692 |
| Jun 11, 2026 | Adam R. Levydirector, officer: Chief Executive Officer | Sale | 3,000 | $0.6136 | 333,692 |
| Jun 8, 2026 | Adam R. Levydirector, officer: Chief Executive Officer | Sale | 3,000 | $0.5470 | 336,692 |
| Jun 4, 2026 | Adam R. Levydirector, officer: Chief Executive Officer | Sale | 3,000 | $0.5936 | 339,692 |
| Jun 1, 2026 | Adam R. Levydirector, officer: Chief Executive Officer | Sale | 2,000 | $0.5859 | 342,692 |
| May 29, 2026 | Adam R. Levydirector, officer: Chief Executive Officer | Sale | 3,000 | $0.6003 | 344,692 |
| May 28, 2026 | Adam R. Levydirector, officer: Chief Executive Officer | Sale | 7,000 | $0.6058 | 347,692 |
| May 27, 2026 | Adam R. Levydirector, officer: Chief Executive Officer | Sale | 3,000 | $0.5975 | 354,692 |
| May 14, 2026 | Adam R. Levydirector, officer: Chief Executive Officer | Purchase · 2 lots | 150,000 | $0.6667 | 150,000 |
CongressHouse and Senate disclosures
Not reported.
